Form 4: Clifford Sosin of CAS Investment Partners Sells Cardlytics Shares

Clifford Sosin, a director at Cardlytics, sold 19,523 shares of common stock at $3.953 per share, while still holding a significant indirect stake through investment partnerships.

Summary

• Clifford Sosin, a director of Cardlytics, sold 19,523 shares of common stock on December 3, 2024, at a price of $3.953 per share.
• Following the transaction, Sosin indirectly beneficially owns 6,400,210 shares of Cardlytics common stock.
• These shares are held through Sosin Master, L.P. and CSWR Partners, L.P., where Sosin's firm, CAS Investment Partners, LLC, acts as the investment manager.
• Sosin Master holds $16,498,366 principal amount of Cardlytics' 4.25% Convertible Senior Notes due 2029, and CSWR holds $7,501,634 of the same notes.
• The notes are convertible into common stock at a rate of 55.4939 shares per $1,000 principal amount, but the company has the option to settle conversions in cash, shares, or a combination of both.
• Due to the company's settlement options, Sosin is not deemed the beneficial owner of the shares underlying the convertible notes for Section 13(d) purposes.

Sentiment

Score: 5

Explanation: The document is neutral, reporting a routine transaction. The sale of shares by a director could be seen as slightly negative, but it's not a major event.

Negatives

• Clifford Sosin, a director, sold a portion of his directly held shares, which could be interpreted negatively by some investors.

Risks

• The company's option to settle convertible notes in cash could dilute the value of existing shares if settled in stock.
• The sale of shares by a director could be perceived as a lack of confidence in the company's future performance.

Future Outlook

The document does not contain any forward-looking statements or guidance.

Industry Context

This filing is a routine disclosure of insider trading activity and does not necessarily reflect broader industry trends. However, it is common for directors and major shareholders to adjust their holdings periodically.

Comparison to Industry Standards

• Insider trading disclosures are a standard practice for publicly traded companies, and this filing is consistent with SEC regulations.
• The sale of shares by a director is not uncommon and can be for various reasons, including personal financial planning.
• The convertible notes are a common financing instrument, and the terms are typical for such securities.

Stakeholder Impact

• The sale of shares by a director could cause a minor negative reaction from shareholders, but the overall impact is likely to be minimal.

Key Dates

Keywords

Cardlytics, CDLX, Clifford Sosin, CAS Investment Partners, Convertible Notes, Share Sale, Beneficial Ownership, SEC Form 4